Medium urgency

Bio-Lab, Inc. v. United States

The U.S. Court of International Trade upheld the final results of an antidumping duty administrative review on certain chemicals from China for 2022-2023, affecting importers of those products.

Aforeworn detected this change in the International Trade & Tariffs (ITC / CBP / USTR) space on July 29, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Importers and customs brokers of subject chemicals from China covered by the antidumping order on Bio-Lab, Inc. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline stated; action should be taken promptly for upcoming entries.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors International Trade & Tariffs (ITC / CBP / USTR) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

The court affirmed the Commerce Department's final results, confirming the antidumping duty rates for the 2022-2023 review period.

Who it affects

Importers and customs brokers of subject chemicals from China covered by the antidumping order on Bio-Lab, Inc.

What you must do

Review the specific duty rates in the final results and ensure correct cash deposit rates are applied to future entries.

Deadline

No specific deadline stated; action should be taken promptly for upcoming entries.

Source: https://www.courtlistener.com/opinion/10927624/bio-lab-inc-v-united-states/

Never miss a change like this again

Aforeworn watches International Trade & Tariffs (ITC / CBP / USTR) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in International Trade & Tariffs (ITC / CBP / USTR)